Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991082528> ?p ?o ?g. }
- W1991082528 endingPage "10227" @default.
- W1991082528 startingPage "10214" @default.
- W1991082528 abstract "ABSTRACT We have shown that bronchoalveolar epithelial A 1 -adenosine receptors (A 1 -AdoR) are activated in influenza A virus-infected mice. Alveolar macrophages and neutrophils also express A 1 -AdoRs, and we hypothesized that activation of A 1 -AdoRs on these cells will promote macrophage and neutrophil chemotaxis and activation and thereby play a role in the pathogenesis of influenza virus-induced acute lung injury. Wild-type (WT) C57BL/6 mice, congenic A 1 -AdoR knockout (A 1 -KO) mice, and mice that had undergone reciprocal bone marrow transfer were inoculated intranasally with 10,000 PFU/mouse influenza A/WSN/33 (H1N1) virus. Alternatively, WT mice underwent daily treatment with the A 1 -AdoR antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) from 1 day prior to inoculation. Infection increased bronchoalveolar lining fluid (BALF) adenosine comparably in WT and A 1 -KO mice. Infection of WT mice resulted in reduced carotid arterial O 2 saturation (hypoxemia), lung pathology, pulmonary edema, reduced lung compliance, increased basal airway resistance, and hyperresponsiveness to methacholine. These effects were absent or significantly attenuated in A 1 -KO mice. Levels of BALF leukocytes, gamma interferon (IFN-γ), and interleukin 10 (IL-10) were significantly reduced in infected A 1 -KO mice, but levels of KC, IP-10, and MCP-1 were increased. Reciprocal bone marrow transfer resulted in WT-like lung injury severity, but BALF leukocyte levels increased only in WT and A 1 -KO mice with WT bone barrow. Hypoxemia, pulmonary edema, and levels of BALF alveolar macrophages, neutrophils, IFN-γ, and IL-10 were reduced in DPCPX-treated WT mice. Levels of viral replication did not differ between mouse strains or treatment groups. These findings indicate that adenosine activation of leukocyte A 1 -AdoRs plays a significant role in their recruitment to the infected lung and contributes to influenza pathogenesis. A 1 -AdoR inhibitor therapy may therefore be beneficial in patients with influenza virus-induced lung injury. IMPORTANCE Because antiviral drugs are of limited efficacy in patients hospitalized for influenza virus-induced respiratory failure, there is an urgent need for new therapeutics that can limit the progression of lung injury and reduce influenza death rates. We show that influenza A virus infection results in increased production of the nucleoside adenosine in the mouse lung and that activation of A 1 -subtype adenosine receptors by adenosine contributes significantly to both recruitment of innate immune cells to the lung and development of acute lung injury following influenza virus infection. We also show that treatment with an A 1 -adenosine receptor antagonist reduces the severity of lung injury in influenza virus-infected mice. Our findings indicate that adenosine plays an important and previously unrecognized role in the innate immune response to influenza virus infection and suggest that drugs which can inhibit either generation of adenosine or activation of A 1 -adenosine receptors may be beneficial in treating influenza patients hospitalized for respiratory failure." @default.
- W1991082528 created "2016-06-24" @default.
- W1991082528 creator A5011421671 @default.
- W1991082528 creator A5077606167 @default.
- W1991082528 creator A5079814684 @default.
- W1991082528 date "2014-09-01" @default.
- W1991082528 modified "2023-10-15" @default.
- W1991082528 title "Activation of A <sub>1</sub> -Adenosine Receptors Promotes Leukocyte Recruitment to the Lung and Attenuates Acute Lung Injury in Mice Infected with Influenza A/WSN/33 (H1N1) Virus" @default.
- W1991082528 cites W1485389808 @default.
- W1991082528 cites W1583031148 @default.
- W1991082528 cites W1664366554 @default.
- W1991082528 cites W171447041 @default.
- W1991082528 cites W1803784511 @default.
- W1991082528 cites W1964050826 @default.
- W1991082528 cites W1979237241 @default.
- W1991082528 cites W1980164431 @default.
- W1991082528 cites W1985056697 @default.
- W1991082528 cites W1985407729 @default.
- W1991082528 cites W1986391395 @default.
- W1991082528 cites W1990819855 @default.
- W1991082528 cites W1996311210 @default.
- W1991082528 cites W2003133798 @default.
- W1991082528 cites W2003483275 @default.
- W1991082528 cites W2006489146 @default.
- W1991082528 cites W2007100673 @default.
- W1991082528 cites W2007611385 @default.
- W1991082528 cites W2008617110 @default.
- W1991082528 cites W2010061071 @default.
- W1991082528 cites W2012496191 @default.
- W1991082528 cites W2015087089 @default.
- W1991082528 cites W2018851086 @default.
- W1991082528 cites W2022335378 @default.
- W1991082528 cites W2031997312 @default.
- W1991082528 cites W2034442219 @default.
- W1991082528 cites W2037529704 @default.
- W1991082528 cites W2039079142 @default.
- W1991082528 cites W2042904632 @default.
- W1991082528 cites W2044591518 @default.
- W1991082528 cites W2052290396 @default.
- W1991082528 cites W2059460122 @default.
- W1991082528 cites W2061600879 @default.
- W1991082528 cites W2062756839 @default.
- W1991082528 cites W2067493370 @default.
- W1991082528 cites W2072898255 @default.
- W1991082528 cites W2076026689 @default.
- W1991082528 cites W2076545903 @default.
- W1991082528 cites W2078990597 @default.
- W1991082528 cites W2079608251 @default.
- W1991082528 cites W2080126451 @default.
- W1991082528 cites W2081792921 @default.
- W1991082528 cites W2082601653 @default.
- W1991082528 cites W2083420798 @default.
- W1991082528 cites W2086727917 @default.
- W1991082528 cites W2087440184 @default.
- W1991082528 cites W2089618502 @default.
- W1991082528 cites W2092073971 @default.
- W1991082528 cites W2093806586 @default.
- W1991082528 cites W2100796791 @default.
- W1991082528 cites W2102291283 @default.
- W1991082528 cites W2105225614 @default.
- W1991082528 cites W2112089376 @default.
- W1991082528 cites W2113246862 @default.
- W1991082528 cites W2114443908 @default.
- W1991082528 cites W2115778648 @default.
- W1991082528 cites W2116077299 @default.
- W1991082528 cites W2117839847 @default.
- W1991082528 cites W2119679690 @default.
- W1991082528 cites W2123551429 @default.
- W1991082528 cites W2127070756 @default.
- W1991082528 cites W2127117200 @default.
- W1991082528 cites W2129234516 @default.
- W1991082528 cites W2129339954 @default.
- W1991082528 cites W2129374660 @default.
- W1991082528 cites W2139372108 @default.
- W1991082528 cites W2139812868 @default.
- W1991082528 cites W2141619353 @default.
- W1991082528 cites W2146351995 @default.
- W1991082528 cites W2147682506 @default.
- W1991082528 cites W2147809951 @default.
- W1991082528 cites W2147954622 @default.
- W1991082528 cites W2151420265 @default.
- W1991082528 cites W2152078343 @default.
- W1991082528 cites W2155461202 @default.
- W1991082528 cites W2157649477 @default.
- W1991082528 cites W2163901715 @default.
- W1991082528 cites W2166798770 @default.
- W1991082528 cites W2167350263 @default.
- W1991082528 cites W2168945217 @default.
- W1991082528 cites W2171177648 @default.
- W1991082528 cites W2270909071 @default.
- W1991082528 cites W2341310110 @default.
- W1991082528 cites W2429150090 @default.
- W1991082528 doi "https://doi.org/10.1128/jvi.01068-14" @default.
- W1991082528 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4136329" @default.
- W1991082528 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24965449" @default.
- W1991082528 hasPublicationYear "2014" @default.
- W1991082528 type Work @default.
- W1991082528 sameAs 1991082528 @default.